Cargando…
Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths
Although nearly 10% of Americans suffer from a rare disease, clinical progress in individual rare diseases is severely compromised by lack of attention and research resources compared to common diseases. It is thus imperative to investigate these diseases at their most basic level to build a foundat...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Company of Biologists Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380043/ https://www.ncbi.nlm.nih.gov/pubmed/34370008 http://dx.doi.org/10.1242/dmm.049010 |